Comparative study between nadolol and 5‐isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial
SUMMARY Background After variceal bleeding, cirrhotic patients should receive secondary prophylaxis. Aim To compare nadolol plus 5‐isosorbide mononitrate (5‐ISMN) with endoscopic band ligation. The end points were rebleeding, treatment failure and death. Methods One hundred and nine cirrhotic pat...
Saved in:
Published in | Alimentary pharmacology & therapeutics Vol. 24; no. 4; pp. 601 - 611 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
15.08.2006
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | SUMMARY
Background After variceal bleeding, cirrhotic patients should receive secondary prophylaxis.
Aim To compare nadolol plus 5‐isosorbide mononitrate (5‐ISMN) with endoscopic band ligation. The end points were rebleeding, treatment failure and death.
Methods One hundred and nine cirrhotic patients with a recent variceal bleeding were randomized: nadolol plus 5‐ISMN in 57 patients and endoscopic band ligation in 52 patients.
Results The mean follow‐up was 17 and 19 months in nadolol plus 5‐ISMN and endoscopic band ligation groups, respectively. No differences were observed between groups in upper rebleeding (47% vs. 46%), variceal rebleeding (40% vs. 36%), failure (32% vs. 22%), major complications (7% vs. 13.5%) and death (19% vs. 20%), respectively. The actuarial probability of remaining free of rebleeding, failure and deaths were similar in both groups. Time to rebleeding shows that endoscopic band ligation patients had an early rebleed, with a median of 0.5 month (95% CI: 0.0–4.2) compared with patients from nadolol plus 5‐ISMN, 7.6 months (95% CI: 2.9–12.3, P < 0.013). Multivariate analysis indicated that outcome‐specific predictive factor(s) for rebleeding was Child A vs. B + C (P < 0.01); for failure was Child A vs. B + C (P < 0.02); and for death ascites (P < 0.01) and rebleeding (P < 0.02).
Conclusion This trial suggests no superiority of endoscopic band ligation over nadolol plus 5‐ISMN mononitrate for the prevention of rebleeding in cirrhotic patients. |
---|---|
Bibliography: | These authors contributed equally to this article. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 0269-2813 1365-2036 |
DOI: | 10.1111/j.1365-2036.2006.03007.x |